EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The changing landscape of Fabry disease: Impact of the inclusion of the GLA-gene in broader NGS or WES based panels on the phenotypic spectrum

Laura van Dussen iD, Emilie V Albers iD, Saskia N van der Crabben iD, Ronald H Lekanne Deprez iD, Astrid S Plomp iD, Mirjam Langeveld iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0358572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Laura van Dussen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, University …. Hauptthemen laut MEDLINE: Fabry Disease, alpha-Galactosidase, High-Throughput Nucleotide Sequencing. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fabry disease (FD) is the most common lysosomal storage disorder in which a severe, classical phenotype as well as a milder, non-classical phenotype can be distinguished. In this study we investigated the impact of the introduction of broader DNA sequencing techniques and subsequently the addition of the GLA-gene to NGS or WES based panels on the type of FD patient that is diagnosed by analyzing changes in the composition of the Dutch Fabry cohort over time. The current study confirms that Fabry disease is a genetically heterogeneous disorder with 64 different GLA variants established in a cohort of 319 patients. The introduction of broader DNA sequencing techniques, applied to a broader range of individuals with less specific symptoms, results in the identification of a higher proportion of individuals with less deleterious GLA variants and consequently a milder clinical phenotype. For the majority of individuals identified using the broader sequencing techniques cardiomyopathy is the presenting and only symptom of the disorder, in contrast to the multisystem classical Fabry disease phenotype. This phenotypic shift should be taken into account when comparing current to historical clinical and treatment effect data and requires tailored genetic counseling and clinical follow-up to prevent both over- and undertreatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fabry Diseasealpha-GalactosidaseHigh-Throughput Nucleotide SequencingHumansPhenotypeFemaleMaleExome SequencingMutationSequence Analysis, DNA

Substanzen

alpha-GalactosidaseGLA protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Amsterdam UMC, Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) Research Institute, University of Amsterdam, Amsterdam, The Netherlands.
  • Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Department of Clinical Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: Laura van Dussen, Emilie V Albers, Saskia N van der Crabben, Ronald H Lekanne Deprez, Astrid S Plomp, Mirjam Langeveld

Zitieren

APA

van Dussen, L., Albers, E. V., van der Crabben, S. N., Lekanne Deprez, R. H., Plomp, A. S., & Langeveld, M. (2026). The changing landscape of Fabry disease: Impact of the inclusion of the GLA-gene in broader NGS or WES based panels on the phenotypic spectrum. PLOS One. https://doi.org/10.1371/journal.pone.0358572

Vancouver

van Dussen L, Albers EV, van der Crabben SN, Lekanne Deprez RH, Plomp AS, Langeveld M. The changing landscape of Fabry disease: Impact of the inclusion of the GLA-gene in broader NGS or WES based panels on the phenotypic spectrum. PLOS One. 2026. doi:10.1371/journal.pone.0358572

BibTeX
@article{vanDussen2026,
  author = {van Dussen, Laura and Albers, Emilie V and van der Crabben, Saskia N and Lekanne Deprez, Ronald H and Plomp, Astrid S and Langeveld, Mirjam},
  title = {The changing landscape of Fabry disease: Impact of the inclusion of the GLA-gene in broader NGS or WES based panels on the phenotypic spectrum},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0358572}
}
Kostenlos starten →